Enhancing Cancer Treatment through Improved Understanding of the Critical Components, Economics and Barriers of Cancer Clinical Trials

Posted: Apr 22, 2010
C-Change and the Coalition of Cancer Cooperative Groups.
KEYWORDS: Regulatory Issues, Cancer


This policy-focused guidance document is meant to improve policy makers’ and other stakeholders’ understanding of the process, economics and barriers related to cancer clinical trials.


This document also highlights the necessity of adequate and sustainable public funding to ensure increased participation and effective clinical trial processes. Sections include: I. Current Clinical Trial Environment II. Economics of Cancer Clinical Trials III. Regulated Environment of Cancer Clinical Trials IV. Barriers to Clinical Trial Participation V. Clinical Trials Outlook